Mycenax Biotech (4726) — Net Asset Quality Index
Mycenax Biotech (4726) has a Net Asset Quality Index of 49.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$3.33 Billion minus total liabilities of NT$1.69 Billion yields net assets of NT$1.64 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 4726 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Mycenax Biotech Net Asset Quality Index Over Time (2017–2024)
This chart shows how Mycenax Biotech's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 49.3%, representing net assets of NT$1.64 Billion against total assets of NT$3.33 Billion TWD. See 4726 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Mycenax Biotech (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Mycenax Biotech from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Mycenax Biotech.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 60.1% | NT$2.02 Billion | NT$3.37 Billion | NT$1.34 Billion | ▼ -4.8 pp |
| 2023 | 64.9% | NT$2.45 Billion | NT$3.77 Billion | NT$1.32 Billion | ▼ -4.8 pp |
| 2022 | 69.7% | NT$3.11 Billion | NT$4.45 Billion | NT$1.35 Billion | ▲ +9.0 pp |
| 2021 | 60.7% | NT$1.91 Billion | NT$3.14 Billion | NT$1.23 Billion | ▼ -8.4 pp |
| 2020 | 69.1% | NT$1.21 Billion | NT$1.75 Billion | NT$540.89 Million | ▼ -9.1 pp |
| 2019 | 78.3% | NT$1.10 Billion | NT$1.41 Billion | NT$306.04 Million | ▼ -2.8 pp |
| 2018 | 81.1% | NT$907.01 Million | NT$1.12 Billion | NT$211.70 Million | ▼ -6.1 pp |
| 2017 | 87.1% | NT$1.14 Billion | NT$1.31 Billion | NT$168.93 Million | — |